Pancreatic Cancer Research

ResearcherKobe UniversityActive in the last 2 years

Masanori Gonda

Matched on ORCID iD 0000-0003-2692-5004; OpenAlex author ID A5053510539. Sources: OpenAlex.

Their work

Papers
12
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2022: 1 paper · 2023: 5 papers · 2024: 3 papers · 2025: none · 2026: 3 papers

Papers 12

  1. Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer. Co-author DOI 10.1007/s00535-025-02321-0↗
  2. Biological Borderline Resectable Pancreatic Cancer Represents a Genetically and Immunologically Aggressive Subtype: A Retrospective Study. Co-author DOI 10.1097/sla.0000000000007075↗
  3. Deep Learning Detection of Direct and Indirect Imaging Findings Associated with Pancreatic Cancer at Contrast-enhanced and Noncontrast CT. Co-author DOI 10.1148/radiol.253122↗
  4. Temporal progression of pancreatic cancer computed tomography findings until diagnosis: A large-scale multicenter study. Co-author DOI 10.1002/ueg2.12557↗
  5. Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-023-02069-5↗
  6. Treatment and Prognosis for Pancreatic Duct Disruption Associated With Pancreatic Cancer: A Case Series of 15 Patients. Co-author DOI 10.7759/cureus.67482↗
  7. Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00535-022-01939-8↗
  8. A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal… Co-author DOI 10.1007/s00535-023-02020-8↗
  9. A case of pancreatic ductal adenocarcinoma concomitant with IgG4-related disease in the pancreas and the stomach. Co-author DOI 10.1007/s12328-023-01814-w↗
  10. Benefits of pancreatic parenchymal endoscopic ultrasonography in predicting microscopic precancerous lesions of pancreatic cancer. Co-author DOI 10.1038/s41598-023-38920-1↗
  11. Association of Sarcopenia with a Poor Prognosis and Decreased Tumor-Infiltrating CD8-Positive T Cells in Pancreatic Ductal Adenocarcinoma: A Retrospective Anal… Co-author DOI 10.1245/s10434-023-13569-2↗
  12. Comprehensive Analysis of Molecular Biologic Characteristics of Pancreatic Ductal Adenocarcinoma Concomitant with Intraductal Papillary Mucinous Neoplasm. Co-author DOI 10.1245/s10434-022-11704-z↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Atsuhiro Masuda · 11 shared papers, 2022–2026 · strength 1.66
  2. Arata Sakai · 11 shared papers, 2022–2026 · strength 1.66
  3. Takashi Kobayashi · 10 shared papers, 2022–2026 · strength 1.46
  4. Takumi Fukumoto · 9 shared papers, 2022–2026 · strength 1.31
  5. Hirochika Toyama · 9 shared papers, 2022–2024 · strength 1.26
  6. Yuzo Kodama · 9 shared papers, 2022–2024 · strength 1.26
  7. Keitaro Sofue · 8 shared papers, 2022–2026 · strength 1.17
  8. Masahiro Tsujimae · 8 shared papers, 2022–2026 · strength 1.14
  9. Mika Miki · 7 shared papers, 2023–2026 · strength 1.10
  10. Kohei Yamakawa · 7 shared papers, 2022–2024 · strength 0.94
  11. Shohei Abe · 7 shared papers, 2022–2024 · strength 0.94
  12. Takeshi Tanaka · 7 shared papers, 2022–2024 · strength 0.93
  13. Yoshiyuki Harada · 6 shared papers, 2023–2026 · strength 0.90
  14. Shigeto Ashina · 6 shared papers, 2022–2026 · strength 0.81
  15. Shigeto Masuda · 6 shared papers, 2022–2024 · strength 0.76
  16. Tomoo Itoh · 6 shared papers, 2022–2024 · strength 0.76
  17. Takuya Ikegawa · 4 shared papers, 2022–2026 · strength 0.58
  18. Ryota Nakano · 3 shared papers, 2022–2024 · strength 0.39
  19. Yuichi Hirata · 2 shared papers, 2024–2026 · strength 0.35
  20. Yoshihide Nanno · 2 shared papers, 2023–2026 · strength 0.33
  21. Yuki Oka · 2 shared papers, 2024 · strength 0.31
  22. Tsuyoshi Hamada · 2 shared papers, 2023 · strength 0.25
  23. Takayuki Kodama · 1 shared paper, 2026 · strength 0.20
  24. Yuzo Kodama · 1 shared paper, 2026 · strength 0.20
  25. Yu Arai · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.